XPH News and Press, SPDR S&P Pharmaceuticals From 08/15/21

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

In any market’s upswing, there are always going to be people who make the case that “it’s different this time”, and historically, most of the time, that argument doesn’t hold up. I have never seen so many interesting and novel therapeutic opportuniti...

According to the most recent healthcare report from the OECD, prescribed medicines here in the United States cost $1025.60 per capita, where the average per capita spending in the developed countries of the OECD is only $567.70. According to the same source, we spend $10,966 per capit...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

The best news last week was the continuing decline in global bond yields, including the 10-year Treasury rate falling below 1.4% last Tuesday. If and when the Fed decides to raise key short-term interest rates, I don’t think they will be able to raise rates by much, since the f...

krblokhin/iStock via Getty Images A new report from Democrats on the House Committee on Oversight and Reform says that pharmaceutical companies have spent more on stock buybacks and paying dividends to investors than on research and development. According to the documents, between 2016 and 20...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

SPDR S&P Pharmaceuticals ETF (XPH) - $0.0836.30-Day SEC Yield of 0.49% as of June 17.Payable Jun 24; for shareholders of record Jun 22; ex-div Jun 21. For further details see: SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0836

From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...